Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: A systematic review

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Perlman, Stacey ^a   Wamai, Richard G ^b   Bain, Paul A ^c   Welty, Thomas ^d   Welty, Edith ^d   Ogembo, Javier Gordon ^e  

^a PATHFINDER INTERNATIONAL   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Cameroon Baptist Convention Health Services   (Cameroon)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; WART VIRUS VACCINE;

AFRICA SOUTH OF THE SAHARA; ARTICLE; ATTITUDE TO HEALTH; CANCER SCREENING; CLINICAL PRACTICE; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; NIGERIA; PEER REVIEW; SYSTEMATIC REVIEW; TREND STUDY; UTERINE CERVIX CANCER; WART VIRUS; COMPLICATION; EARLY DIAGNOSIS; EPIDEMIOLOGY; FEMALE; HEALTH SURVEY; IMMUNOLOGY; META ANALYSIS; PAPILLOMAVIRUS INFECTIONS; PATIENT ATTITUDE; UTERINE CERVICAL NEOPLASMS;

AFRICA SOUTH OF THE SAHARA; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; EARLY DETECTION OF CANCER; EPIDEMIOLOGIC FACTORS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; PUBLIC HEALTH SURVEILLANCE; UTERINE CERVICAL NEOPLASMS;

EID: 84897483702     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090912     Document Type: Article

References (70)

1. Chauke-Moagi BE, Mumba M (2012) New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs. Vaccine 30: C3-C8.
2. Levine OS, Bloom DE, Cherian T, de Quadros C, Sow S, et al. (2011) The future of immunisation policy, implementation, and financing. The Lancet 378: 439-448.
3. WHO (2012) WHO and UNICEF. Progress towards global immunization goals - 2011. Geneva: World Health Organization. 35 p. p.
4. Ozawa S, Stack ML, Bishai DM, Mirelman A, Friberg IK, et al. (2011) During the 'decade of vaccines,' the lives of 6.4 million children valued at $231 billion could be saved. Health Affairs 30: 1010-1020.
5. Knaul FM, Frenk J, Shulman L (2011) Global Task Force on Expanded Access to cancer care and control in developing countries.
6. Machingaidze S, Wiysonge CS, Hussey GD (2013) Strengthening the Expanded Programme on Immunization in Africa: Looking beyond 2015. PLoS medicine 10: e1001405.
7. Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. International journal of cancer 118: 3030-3044.
8. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer 127: 2893-2917.
9. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA: a cancer journal for clinicians 61: 69-90.
10. Markowitz LE, Dunne E, Saraiya M, Lawson H, Chesson H, et al. (2007) Quadrivalent human papillomavirus vaccine. Morbidity and Mortality weekly report 56: 1-24.
11. Agosti JM, Goldie SJ (2007) Introducing HPV vaccine in developing countries-key challenges and issues. New England Journal of Medicine 356: 1908-1910. (Pubitemid 46740300)
12. Gakidou E, Nordhagen S, Obermeyer Z (2008) Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS medicine 5: e132.
13. Sitas F, Parkin M, Chirenje Z, Stein L, Mqoqi N, et al. (2006) Disease and mortality in sub-Saharan Africa. World Bank-free PDF.
14. Francis SA, Nelson J, Liverpool J, Soogun S, Mofammere N, et al. (2010) Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa. Vaccine 28: 8026-8032.
15. Ayissi CA, Wamai RG, Oduwo GO, Perlman S, Welty E, et al. (2012) Awareness, Acceptability and Uptake of Human Papilloma Virus Vaccine Among Cameroonian School-Attending Female Adolescents. Journal of community health 37: 1127-1135.
16. Chan ZC, Chan TS, Ng KK, Wong ML (2012) A Systematic Review of Literature about Women's Knowledge and Attitudes toward Human Papillomavirus (HPV) Vaccination. Public Health Nursing 29: 481-489.
17. Wamai RG, Ayissi CA, Oduwo GO, Perlman S, Welty E, et al. (2012) Assessing the effectiveness of a community-based sensitization strategy in creating awareness about HPV, cervical cancer and HPV vaccine among parents in North West Cameroon. Journal of community health 37: 917-926.
18. Wamai RG, Ayissi CA, Oduwo GO, Perlman S, Welty E, et al. (2013) Awareness, knowledge and beliefs about HPV, cervical cancer and HPV vaccines among nurses in Cameroon: an exploratory study. Int J Nurs Stud 50: 1399-1406.
19. Louie KS, De Sanjose S, Mayaud P (2009) Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Tropical Medicine & International Health 14: 1287-1302.
20. WHO (2009) Human papillomavirus vaccines. WHO position paper. 118-131 p.
21. Youngblood R (2013) GAVI injects new life into HPV vaccine rollout. Lancet 381: 1688.
22. GAVI (2011) GAVI welcomes lower prices for life-saving vaccines.[press release], June 6, 2011.
23. Agosti JM, Goldie SJ (2007) Introducing HPV vaccine in developing countries-key challenges and issues. New England Journal of Medicine 356: 1908-1910. (Pubitemid 46740300)
24. Wigle J, Coast E, Watson-Jones D (2013) Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects. Vaccine.
25. Binagwaho A, Wagner CM, Gatera M, Karema C, Nutt CT, et al. (2012) Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bulletin of the World Health Organization 90: 623-628.
26. Binagwaho A, Wagner CM, Nutt CT (2011) HPV vaccine in Rwanda: different disease, same double standard. The Lancet 378: 1916.
27. Ouedraogo N, Müller O, Jahn A, Gerhardus A (2011) Human papillomavirus vaccination in Africa. The Lancet 378: 315-316.
28. LaMontagne DS, Barge S, Thi Le N, Mugisha E, Penny ME, et al. (2011) Human papillomavirus vaccine delivery strategies that achieved high coverage in low-and middle-income countries. Bulletin of the World Health Organization 89: 821-830.
29. Watson-Jones D, Baisley K, Ponsiano R, Lemme F, Remes P, et al. (2012) Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. Journal of Infectious Diseases 206: 678-686.
30. Ladner J, Besson MH, Hampshire R, Tapert L, Chirenje M, et al. (2012) Assessment of eight HPV vaccination programs implemented in lowest income countries. BMC Public Health 12: 370.
31. Moodley I, Tathiah N, Mubaiwa V, Denny L (2013) High uptake of Gardasil vaccine among 9-12-year-old schoolgirls participating in an HPV vaccination demonstration project in KwaZulu-Natal, South Africa. SAMJ: South African Medical Journal 103: 313-317.
32. Anorlu RI (2008) Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters 16: 41-49.
33. Ebosse Y (2010) Mama Fouda authorizes a vaccine that kills. Le Soir Hebd. Yaounde, Cameroon: The Evening Weekly.
34. Gilmour S, Kanda M, Kusumi E, Tanimoto T, Kami M, et al. (2013) HPV vaccination programme in Japan. The Lancet 382: 768.
35. Larson HJ, Brocard P, Garnett G (2010) The India HPV-vaccine suspension. The Lancet 376: 572-573.
36. Khan KS, Ter Riet G, Glanville J, Sowden AJ, Kleijnen J (2001) Undertaking systematic reviews of research on effectiveness: CRD's guidance for carrying out or commissioning reviews: NHS Centre for Reviews and Dissemination.
37. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine 151: 264-269.
38. Tan TP, Stokes T, Shaw EJ (2009) Use of qualitative research as evidence in the clinical guideline program of the National Institute for Health and Clinical Excellence. International Journal of Evidence-Based Healthcare 7: 169-172.
39. Petticrew M, Roberts H (2008) Systematic reviews in the social sciences: A practical guide: Wiley. com.
40. DiAngi YT, Panozzo CA, Ramogola-Masire D, Steenhoff AP, Brewer NT (2011) A cross-sectional study of HPV vaccine acceptability in Gaborone, Botswana. PloS one 6: e25481.
41. Coleman MA, Levison J, Sangi-Haghpeykar H (2011) HPV vaccine acceptability in Ghana, West Africa. Vaccine 29: 3945-3950.
42. Iliyasu Z, Abubakar I, Aliyu M, Galadanci H (2010) Cervical cancer risk perception and predictors of human papilloma virus vaccine acceptance among female university students in northern Nigeria. Journal of Obstetrics &Gynaecology 30: 857-862.
43. Makwe CC, Anorlu RI (2011) Knowledge of and attitude toward human papillomavirus infection and vaccines among female nurses at a tertiary hospital in Nigeria. International journal of women's health 3: 313.
44. Mingo AM, Panozzo CA, DiAngi YT, Smith JS, Steenhoff AP, et al. (2012) Cervical cancer awareness and screening in Botswana. Int J Gynecol Cancer 22: 638-644.
45. Omer SB, Orenstein WA, Koplan JP (2013) Go Big and Go Fast-Vaccine Refusal and Disease Eradication. New England Journal of Medicine 368: 1374-1376.
46. Crowcroft NS, McKenzie KJ (2013) Inoculating communities against vaccine scare stories. Lancet Infect Dis 13: 564-565.
47. Bean SJ (2011) Emerging and continuing trends in vaccine opposition website content. Vaccine 29: 1874-1880.
48. Larson HJ, Heymann DL (2010) Public health response to influenza A (H1N1) as an opportunity to build public trust. JAMA: The Journal of the American Medical Association 303: 271-272.
49. Paterson P, Larson HJ (2012) The role of publics in the introduction of new vaccines. Health policy and planning 27: ii77-ii79.
50. Larson HJ, Smith DM, Paterson P, Cumming M, Eckersberger E, et al. (2013) Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines. Lancet Infect Dis 13: 606-613.
51. Friedrich M (2013) Killings in Nigeria. JAMA 309: 1101-1101.
52. Allen JD, Coronado GD, Williams RS, Glenn B, Escoffery C, et al. (2010) A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine 28: 4027-4037.
53. Liu FW, Vwalika B, Hacker MR, Allen S, Awtrey CS (2012) Cervical Cancer and HPV Vaccination: Knowledge and Attitudes of Adult Women in Lusaka, Zambia. Journal of Vaccines & Vaccination.
54. Remes P, Selestine V, Changalucha J, Ross D, Wight D, et al. (2012) A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania. Vaccine.
55. Ugwu EO, Obi SN, Ezechukwu PC, Okafor, II, Ugwu AO (2013) Acceptability of human papilloma virus vaccine and cervical cancer screening among female health-care workers in Enugu, Southeast Nigeria. Niger J Clin Pract 16: 249-252.
56. Mupepi SC, Sampselle CM, Johnson TR (2011) Knowledge, attitudes, and demographic factors influencing cervical cancer screening behavior of Zimbabwean women. Journal of Women's Health 20: 943-952.
57. McCarey C, Pirek D, Tebeu P, Boulvain M, Doh A, et al. (2011) Awareness of HPV and cervical cancer prevention among Cameroonian healthcare workers. BMC women's health 11: 45.
58. Wamai RG, Ayissi CA, Oduwo GO, Perlman S, Welty E, et al. (2013) Awareness, knowledge and beliefs about HPV, cervical cancer and HPV vaccines among nurses in Cameroon: An exploratory study. International journal of nursing studies.
59. Rositch AF, Gatuguta A, Choi RY, Guthrie BL, Mackelprang RD, et al. (2012) Knowledge and acceptability of pap smears, self-sampling and HPV vaccination among adult women in Kenya. PLoS One 7: e40766.
60. Poole D, Tracy K, Levitz L, Yekta S, Kossow E, et al. (2012) Knowledge/attitude/practices of HPV & cervical cancer, willingness to participate in vaccine trial in preparation for HIV & HPV vaccine trials in Mali. Retrovirology 9: O27.
61. Becker-Dreps S, Otieno WA, Brewer NT, Agot K, Smith JS (2010) HPV vaccine acceptability among Kenyan women. Vaccine 28: 4864-4867.
62. Nelson JA, Francis SA, Liverpool J, Soogun S, Mofammere N (2010) Healers in a non-traditional role; a focus group study of Sangoma's knowledge of and attitudes to cervical cancer prevention and screening in Johannesburg, South Africa. Sexual & Reproductive Healthcare 1: 195-196.
63. Maher D, Ford N, Unwin N (2012) Priorities for developing countries in the global response to non-communicable diseases. Globalization and Health 8: 1-8.
64. Urasa M, Darj E (2011) Knowledge of cervical cancer and screening practices of nurses at a regional hospital in Tanzania. African health sciences 11.
65. Mbamara SU, Ikpeze OC, Okonkwo J, Onyiaorah IV, Ukah CO (2011) Knowledge, attitude and practice of cervical cancer screening among women attending gynecology clinics in a tertiary level medical care center in southeastern Nigeria. The Journal of reproductive medicine 56: 491-496.
66. Francis SA, Battle-Fisher M, Liverpool J, Hipple L, Mosavel M, et al. (2011) A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health. Vaccine 29: 8760-8765.
67. Morhason-Bello I, Oladokun A, Adedokun B, Adesina O, Awolude O, et al. (2009) Introduction of human papilloma virus vaccine in a low resource setting: a survey of the views of Nigerian gynaecologists. International Journal of Gynecology & Obstetrics 107: S274.
68. Watson-Jones D, Tomlin K, Remes P, Baisley K, Ponsiano R, et al. (2012) Reasons for Receiving or Not Receiving HPV Vaccination in Primary Schoolgirls in Tanzania: A Case Control Study. PLoS One 7: e45231.
69. Galagan SR, Paul P, Menezes L, LaMontagne DS (2013) Influences on parental acceptance of HPV vaccination in demonstration projects in Uganda and Vietnam. Vaccine.
70. Banura C, Mirembe FM, Katahoire AR, Namujju PB, Mbidde EK (2012) Universal routine HPV vaccination for young girls in Uganda: a review of opportunities and potential obstacles. Infectious agents and cancer 7: 24.